Literature DB >> 11162129

Structural alterations in cardiac calcium release units resulting from overexpression of junctin.

L Zhang1, C Franzini-Armstrong, V Ramesh, L R Jones.   

Abstract

Junctin is a 26 kDa membrane protein that binds to calsequestrin, triadin, and ryanodine receptors (RyRs) within the junctional sarcoplasmic reticulum of calcium release units. The sequence of junctin includes a short N-terminal cytoplasmic domain a single transmembrane domain, and a highly charged C-terminal domain located in the sarcoplasmic reticulum lumen. Dog and mouse junctins are highly conserved at the transmembrane domains, but the luminal domains are more divergent. To probe the contribution of junctin to the architecture of calcium release units in heart, we engineered transgenic mice overexpressing canine junctin and examined the left ventricular myocardium by electron microscopy. Overall architecture of calcium release units is similar in control myocardium and in myocardium overexpressing junctin by 5-10-fold. In both myocardia, junctional SR cisternae are closely associated with exterior membranes (plasmalemma and transverse tubules). The cisternae are flat; they contain a string of calsequestrin beads and are lined by a row of feet, or RyRs, on the side facing the exterior membranes. T tubule surface density, measured as the perimeter of T tubule profiles v area of section, is the same in transgenic and control myocardia (305 v 289 nm/nm(2)). Three changes affecting the junctional SR architecture are apparent in the myocardium overexpressing junctin. One is a more tightly zippered appearance of the junctional SR cisternae. The width of the junctional SR is narrower and less variable in overexpressing than in control myocardium and the calsequestrin content is more compact. A second change is the extension of zippered junctional SR domains to non-junctional regions, which we term "frustrated" junctional SR. A third change is an increase in the extent of association between SR and T tubules. In junctin overexpressing myocardium junctional SR cisternae cover approximately 45% of the surface of all T tubule profiles, while in control myocardium the coverage approximately 30%. Junctional associations between SR and T tubules are increased in size. We conclude that the increase in junctin expression affects the packing of calsequestrin in the junctional SR and facilitates the association of SR and T tubules. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162129     DOI: 10.1006/jmcc.2000.1295

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  21 in total

1.  Novel details of calsequestrin gel conformation in situ.

Authors:  Stefano Perni; Matthew Close; Clara Franzini-Armstrong
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

2.  Axial tubules of rat ventricular myocytes form multiple junctions with the sarcoplasmic reticulum.

Authors:  Parisa Asghari; Meredith Schulson; David R L Scriven; Garnet Martens; Edwin D W Moore
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

Review 3.  Triadin, not essential, but useful.

Authors:  Paul D Allen
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

Review 4.  Functional interaction between calsequestrin and ryanodine receptor in the heart.

Authors:  Marta Gaburjakova; Naresh C Bal; Jana Gaburjakova; Muthu Periasamy
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

5.  Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.

Authors:  Anuradha Kalyanasundaram; Serge Viatchenko-Karpinski; Andriy E Belevych; Veronique A Lacombe; Hyun Seok Hwang; Björn C Knollmann; Sandor Gyorke; Muthu Periasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

6.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

Review 7.  Regulatory roles of junctin in sarcoplasmic reticulum calcium cycling and myocardial function.

Authors:  Guo-Chang Fan; Qunying Yuan; Evangelia G Kranias
Journal:  Trends Cardiovasc Med       Date:  2008-01       Impact factor: 6.677

Review 8.  Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.

Authors:  Sandor Györke; Cynthia Carnes
Journal:  Pharmacol Ther       Date:  2008-07-12       Impact factor: 12.310

9.  Partial downregulation of junctin enhances cardiac calcium cycling without eliciting ventricular arrhythmias in mice.

Authors:  Qunying Yuan; Peidong Han; Min Dong; Xiaoping Ren; Xiaoyang Zhou; Shan Chen; W Keith Jones; Guoxiang Chu; Hong-Sheng Wang; Evangelia G Kranias
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

10.  Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias.

Authors:  Nagesh Chopra; Tao Yang; Parisa Asghari; Edwin D Moore; Sabine Huke; Brandy Akin; Robert A Cattolica; Claudio F Perez; Thinn Hlaing; Barbara E C Knollmann-Ritschel; Larry R Jones; Isaac N Pessah; Paul D Allen; Clara Franzini-Armstrong; Björn C Knollmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.